Dr. Michael Har-Noy Highlights The Curative Potential Of Cancer Immunotherapy

Dr. Michael Har-Noy, CEO and founder of Immunovative Therapies, Ltd., a biotechnology company in Israel, says that the immunotherapy of cancer attempts to restore the ability of the patient’s immune system to seek out and remove malignant cells. Along with chemotherapy, radiation and surgery used in the therapy of cancer.

Dr. Michael Har-Noy says that immunotherapeutic agents are created to capture the power of the patient’s own immune system, and that they enable the system to stop tumor growth and eliminate metastatic spread.

Because cancer starts as a microscopic process, says Dr. Michael Har-Noy, it is impossible to locate every last malignant cell in the body. Conventional treatment methods of chemotherapy, radiation, and surgery are not thorough enough to find and remove every last cancer cell. If every last tumor cell is not eradicated with treatment, then the remaining malignant cells will usually grow back and cause a relapse of the disease. When the cancer returns after the initial treatment, says Dr. Michael Har-Noy, it is usually much more refractory to further therapy using the same conventional methods. Therefore, we need new treatment modalities to win the battle against cancer.

Dr. Michael Har-Noy points out that only immunotherapy has the potential to eliminate every last cancer cell in the body. He says that a patient’s immune system is actually capable of ‘sterilizing’ his or her body from malignant cancer cells, just as it able to rid his or her body of viruses and bacteria. Also, unlike conventional cancer treatments, immunologic therapies recruit the patient’s immune system’s “memory”. Dr. Michael Har-Noy describes this as a process whereby if the patient’s immune system eliminates a disease-causing pathogen after the first exposure, it can then program immune cells that remember how this elimination process occurred. Then, if the same pathogen encounter the body again, the patient’s immune system is pre-programmed to remove it without any further therapy.

Dr. Michael Har-Noy goes on to note that if a patient’s immune system can be programmed to eliminate cancer cells through vaccination, then that immune system give the patient lifetime protection against recurrence of the same tumor. After a malignancy is eradicated by immune encounter, the immune cells ‘remembers’ how this successful elimination took place. Thus, says Dr. Michael Har-Noy, a properly trained immune system can eliminate recurrent malignancies before they become clinically apparent.

Dr. Michael Har-Noy adds that when a patient’s immune system is conditioned to both eliminate existing malignant cells and protect them against their return, that patient virtually “immune” to the tumor. A patient that remains immune to these cancer cells can experience long term remission from the disease. This is what fundamentally constitutes a cure.

Please visit www.immunocare.net for more information.